Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$655K Sell
149,499
-22,811
-13% -$101K 0.02% 478
2025
Q4
$748K Sell
172,310
-27,000
-14% -$100K 0.02% 423
2025
Q3
$665K Hold
199,310
0.02% 361
2025
Q2
$704K Buy
199,310
+70,827
+55% +$207K 0.02% 358
2025
Q1
$348K Hold
128,483
0.01% 418
2024
Q4
$391K Buy
+128,483
New +$422K 0.01% 381

Other funds holding PYPD

J. Goldman & Co's PYPD Position: Q1 2026 in Review

J. Goldman & Co reduced its PolyPid (PYPD) stake by 13% in Q1 2026, selling an estimated $101K and leaving 149,499 shares worth $655K. The position accounts for 0.02% of the portfolio, ranked #478.

J. Goldman & Co first reported a position in PYPD in Q4 2024 and has held it in 6 quarters since. The position peaked at $748K in Q4 2025. 19 funds tracked by Wall St. Rank hold PYPD as of Q1 2026.

  • J. Goldman & Co held 149,499 shares of PolyPid worth $655K as of Q1 2026.
  • J. Goldman & Co sold 22,811 PolyPid shares in Q1 2026, an estimated $101K.
  • PolyPid made up 0.02% of J. Goldman & Co's portfolio in Q1 2026, its #478 holding.
  • J. Goldman & Co first reported a position in PolyPid in Q4 2024 and has held it in 6 quarters since.
  • J. Goldman & Co's PolyPid position peaked at $748K in Q4 2025.
  • 19 funds tracked by Wall St. Rank held PolyPid as of Q1 2026.

Based on J. Goldman & Co's 13F filing for Q1 2026, filed 15 May 2026.